A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment
一项针对多发性硬化症伴行走障碍患者的ADS-5102（金刚烷胺）缓释胶囊的3期双盲、安慰剂对照疗效和安全性研究
期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585211035333
Cohen, Jeffrey A; Cameron, Michelle H; Goldman, Myla D; Goodman, Andrew D; Miller, Aaron E; Rollins, Anne; Llorens, Lily; Patni, Rajiv; Elfont, Robert; Johnson, Reed
